What Is New - Paediatric Rheumatological Conditions
Take a look at our 'What is new' highlights in paediatric rheumatology!
"Psoriasis rate is increased by the exposure to TNF inhibition in children with JIA"
This large analysis of real-world data, including >8000 children and young people with JIA, identified that the risk of new onset TNF inhibitor-associated psoriasis was ~5.6 times higher (adjusted for methotrexate, sex, race, family history of psoriasis, and ILAR) in those with non-psoriatic arthritis compared with those not treated with TNF inhibitors.
Would you be more likely to report new-onset psoriasis in JIA for those on TNFi – could this higher rate be influenced by reporting bias?
Join the discussion on twitter... Share your response with us using the hastag #WhatIsNew and tag us @EMEUNET
Click here to be directed to the article by Cann et al (2018).
Childhood-onset rheumatic diseases / Bone health
Click here to be directed to the article by Inoue et al (2018).
Juvenile localised scleroderma
Click here to be directed to the article by Agazzi et al (2018).
Click here to be directed to the article by Zhang et al (2018).
Click here to be directed to the article by Yeker et al (2018).
Juvenile idiopathic arthritis
Click here to be directed to the article by Höfel et al (2018).